Endo I - Search Results

1

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.

Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M. Higa Y, et al. Among authors: endo i. Antioxidants (Basel). 2023 Jan 5;12(1):133. doi: 10.3390/antiox12010133. Antioxidants (Basel). 2023. PMID: 36670994 Free PMC article.

2

Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases.

Umaki Y, Mitsui T, Endo I, Akaike M, Matsumoto T. Umaki Y, et al. Among authors: endo i. Acta Neuropathol. 2002 Feb;103(2):163-70. doi: 10.1007/s004010100446. Epub 2001 Oct 31. Acta Neuropathol. 2002. PMID: 11810183

3

Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome.

Endo I, Mitsui T, Nishino M, Oshima Y, Matsumoto T. Endo I, et al. Intern Med. 2002 Dec;41(12):1196-8. doi: 10.2169/internalmedicine.41.1196. Intern Med. 2002. PMID: 12521215 Free article.

4

Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors.

Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T. Endo I, et al. Endocrinology. 2003 Dec;144(12):5138-44. doi: 10.1210/en.2003-0502. Epub 2003 Aug 13. Endocrinology. 2003. PMID: 12959989

5

[Primary hyperparathyroidism].

Endo I, Matsumoto T. Endo I, et al. Nihon Rinsho. 2006 Sep;64(9):1718-23. Nihon Rinsho. 2006. PMID: 16972686 Review. Japanese.

6

Beneficial effect of tacrolimus on myasthenia gravis with thymoma.

Mitsui T, Kunishige M, Ichimiya M, Shichijo K, Endo I, Matsumoto T. Mitsui T, et al. Among authors: endo i. Neurologist. 2007 Mar;13(2):83-6. doi: 10.1097/01.nrl.0000256352.77668.ef. Neurologist. 2007. PMID: 17351528 Clinical Trial.

7

[Progress in diagnosis of and therapy for hypocalcemia: Differential diagnosis and classification of hypoparathyroidism].

Endo I, Matsumoto T. Endo I, et al. Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):688-95. doi: 10.2169/naika.96.688. Nihon Naika Gakkai Zasshi. 2007. PMID: 17506305 Review. Japanese. No abstract available.

8

[Pathophysiology and classitication of parathyroidism].

Endo I, Matsumoto T, Fukumoto S. Endo I, et al. Clin Calcium. 2007 Aug;17(8):1175-81. Clin Calcium. 2007. PMID: 17660612 Review. Japanese.

9

[Phosphatonin].

Endo I, Matsumoto T. Endo I, et al. Clin Calcium. 2007 Oct;17(10):1580-4. Clin Calcium. 2007. PMID: 17906412 Review. Japanese.

10

[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].

Endo I, Matsumoto T. Endo I, et al. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:443-6. Nihon Rinsho. 2007. PMID: 18161146 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,094 results

Search Page